SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : T/FIF, a New Plateau

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: scaram(o)uche who wrote (716)11/6/2001 9:11:14 PM
From: scaram(o)uche  Read Replies (1) of 2243
 
FREE FULL-TEXT ACCESS TO NATURE CANCER UPDATE

To ease the information overload, Nature Publishing Group has created a
fast, convenient and easily accessible cancer research resource -
Nature Cancer Update - available at nature.com

We invite you to take advantage of this resource with a limited offer.
Until 1st January 2002, all full-text articles available through Nature
Cancer Update will be FREE OF CHARGE. You will have full, unrestricted
access to cancer research, published by Nature Publishing Group,
highlighted in the following sections:

- Hot off the press
- Reviews
- Research Round-up
- Policy News

Visit nature.com to ensure you don't miss out.

The site is regularly updated with news and research from the Nature News
Service and Nature Publishing Group's cancer journals. You can also sign
up for a free e-alert, making the science come to you.

To take advantage of this offer click on nature.com now
- remember that FREE full-text is only available until 1st January 2002.

Yours faithfully

Tim Redding
Marketing Manager - Nature Cancer Update

Nature Cancer Update - the one-stop online resource for cancer news and
research.

Nature Cancer Update is supported by an educational grant from
AstraZeneca, a world leader in oncology research that is committed
to the development of endocrine and cytotoxic treatments, as well as
new approaches to cancer therapy. Visit us at
astrazeneca.com, or, for latest
news, astrazeneca.com.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext